Bluesail+ 蓝帆医疗 2025 Annual Internal Control Self-Evaluation Report
Bluesail Medical Co., Ltd. 2025 Annual Internal Control Self-Evaluation Report
To all shareholders of Bluesail Medical Co., Ltd.:
Pursuant to the "Basic Norms for Enterprise Internal Control" and its supporting guidelines, as well as other internal control regulatory requirements (hereinafter referred to as the "Enterprise Internal Control Norms System"), and in conjunction with the internal control system and evaluation methods of Bluesail Medical Co., Ltd. (hereinafter referred to as the "Company" or "this Company"), based on daily supervision and special supervision of internal controls, we have evaluated the effectiveness of the Company's internal controls as of December 31, 2025 (the base date of the internal control evaluation report).
I. Important Statement
In accordance with the requirements of the Enterprise Internal Control Norms System, establishing and effectively implementing internal controls, evaluating their effectiveness, and truthfully disclosing the internal control evaluation report are the responsibilities of the Company's Board of Directors. The Audit Committee supervises the establishment and implementation of internal controls by the Board of Directors. The management is responsible for organizing and leading the daily operations of the Company's internal controls. The Board of Directors, directors, and senior management of the Company guarantee that the content of this report contains no false records, misleading statements, or significant omissions, and they shall bear individual and joint legal liability for the truthfulness, accuracy, and completeness of the report.